StockData
Bio Key International Inc logo

Bio Key International Inc (BKYI) stock

BKYINasdaqServices-Prepackaged SoftwareFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/3073% below fair value
$1.99+0.05 (+2.58%)

Close on Nov 18, 2026Market cap $2.86MP/E –Yield –

Bio Key International cash

Cash and short-term investments held at the end of each period.

Bio Key International's cash was $1.38M at Jun 30, 2026. For fiscal 2025 it was $2.69M, up 515.8% from the year before. Over ten years it grew -4.6% a year on average. The highest annual figure on record is $16.99M in fiscal 2020.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.69M+515.8%
FY2024Dec 31, 2024$437.60K-14.4%
FY2023Dec 31, 2023$511.40K-80.6%
FY2022Dec 31, 2022$2.64M-66.0%
FY2021Dec 31, 2021$7.75M-54.4%
FY2020Dec 31, 2020$16.99M+21406.7%
FY2019Dec 31, 2019$79.01K-75.6%
FY2018Dec 31, 2018$323.94K+12.2%
FY2017Dec 31, 2017$288.72K-72.8%
FY2016Dec 31, 2016$1.06M-75.4%
FY2015Dec 31, 2015$4.32M+412.2%
FY2014Dec 31, 2014$843.63K-58.3%
FY2013Dec 31, 2013$2.02M+2309.1%
FY2012Dec 31, 2012$83.99K+93.4%
FY2011Dec 31, 2011$43.44K-95.7%
FY2010Dec 31, 2010$1.01M+27.5%
FY2009Dec 31, 2009$792.43K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.38M-39.4%
Q1 FY2026Mar 31, 2026$2.25M-28.3%
Q4 FY2025Dec 31, 2025$2.69M+515.8%
Q3 FY2025Sep 30, 2025$2.04M+13.3%
Q2 FY2025Jun 30, 2025$2.28M+80.5%
Q1 FY2025Mar 31, 2025$3.13M+353.9%
Q4 FY2024Dec 31, 2024$437.60K-14.4%
Q3 FY2024Sep 30, 2024$1.80M+486.5%
Q2 FY2024Jun 30, 2024$1.26M+122.9%
Q1 FY2024Mar 31, 2024$690.45K-4.4%
Q4 FY2023Dec 31, 2023$511.40K-80.6%
Q3 FY2023Sep 30, 2023$307.09K-88.9%
Q2 FY2023Jun 30, 2023$565.51K-88.4%
Q1 FY2023Mar 31, 2023$722.34K-87.5%
Q4 FY2022Dec 31, 2022$2.64M-66.0%
Q3 FY2022Sep 30, 2022$2.77M-71.1%
Q2 FY2022Jun 30, 2022$4.89M-57.4%
Q1 FY2022Mar 31, 2022$5.80M-57.1%
Q4 FY2021Dec 31, 2021$7.75M-54.4%
Q3 FY2021Sep 30, 2021$9.59M-47.9%
Q2 FY2021Jun 30, 2021$11.48M+1194.7%
Q1 FY2021Mar 31, 2021$13.53M+1943.8%
Q4 FY2020Dec 31, 2020$16.99M+21406.7%
Q3 FY2020Sep 30, 2020$18.40M+23411.6%
Q2 FY2020Jun 30, 2020$886.66K+29.1%
Q1 FY2020Mar 31, 2020$661.94K+44.1%
Q4 FY2019Dec 31, 2019$79.01K-75.6%
Q3 FY2019Sep 30, 2019$78.24K-92.5%
Q2 FY2019Jun 30, 2019$687.02K+126.0%
Q1 FY2019Mar 31, 2019$459.31K-64.7%
Q4 FY2018Dec 31, 2018$323.94K+12.2%
Q3 FY2018Sep 30, 2018$1.05M+7.9%
Q2 FY2018Jun 30, 2018$304.01K-69.2%
Q1 FY2018Mar 31, 2018$1.30M+12.2%
Q4 FY2017Dec 31, 2017$288.72K-72.8%
Q3 FY2017Sep 30, 2017$971.86K+447.9%
Q2 FY2017Jun 30, 2017$988.34K–
Q1 FY2017Mar 31, 2017$1.16M–
Q4 FY2016Dec 31, 2016$1.06M–
Q3 FY2016Sep 30, 2016$177.39K–

More Bio Key International figures

See a number that looks wrong?